We are live on ! Find out more
HURA

TuHURA Biosciences
HURA

10 hedge funds and large institutions have $464K invested in TuHURA Biosciences in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

24% more capital invested

Capital invested by funds: $375K → $464K (+$88.5K)

0.12% more ownership

Funds ownership: 0% → 0.12% (+0.12%)

58% less funds holding

Funds holding: 24 → 10 (-14)

93% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 15

Holders
10
Holders Change
-14
Holders Change %
-58.33%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
2
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$53.3K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$44.2K
3
Morgan Stanley
Morgan Stanley
New York
+$26.7K
4
LC
Lindbrook Capital
California
+$13.6K
5
UBS Group
UBS Group
Switzerland
+$2.67K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$30K
2
S
swisspartners
Liechtenstein
-$30K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$28.2K
4
VF
Virtu Financial
New York
-$18K
5
LPL Financial
LPL Financial
California
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$102K +$222 +1 +0.2%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$97K +$44.2K +199 +97%
NCM
3
Nantahala Capital Management
Connecticut
$82K – – –
State Street
4
State Street
Massachusetts
$73.9K +$53.3K +240 +364%
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$44K -$28.2K -127 -41%
Morgan Stanley
6
Morgan Stanley
New York
$29.3K +$26.7K +120 +12,000%
LC
7
Lindbrook Capital
California
$14.7K +$13.6K +61 New
UBS Group
8
UBS Group
Switzerland
$9.67K +$2.67K +12 +43%
Osaic Holdings
9
Osaic Holdings
Arizona
$7K – – –
TRCT
10
Tower Research Capital (TRC)
New York
$4K -$222 -1 -6%
Wells Fargo
11
Wells Fargo
California
$76 – – –
Bank of America
12
Bank of America
North Carolina
$7 – – –
Renaissance Technologies
13
Renaissance Technologies
New York
– -$30K -157 Closed
S
14
swisspartners
Liechtenstein
– -$30K -157 Closed
VF
15
Virtu Financial
New York
– -$18K -94 Closed
LPL Financial
16
LPL Financial
California
– -$5K -26 Closed
Northern Trust
17
Northern Trust
Illinois
– -$5K -25 Closed
HF
18
HRT Financial
New York
– -$4K -22 Closed
TSS
19
Two Sigma Securities
New York
– -$3K -17 Closed
ECM
20
Evergreen Capital Management
Washington
– -$3K -14 Closed
ACA
21
Affinity Capital Advisors
California
– -$2K -13 Closed
Millennium Management
22
Millennium Management
New York
– -$2K -12 Closed
PFO
23
Pathstone Family Office
New Jersey
– -$2.08K -11 Closed
Jane Street
24
Jane Street
New York
– -$2K -10 Closed
Mariner
25
Mariner
Kansas
– -$2K -10 Closed
1
2

HURA Hedge Fund Activity: Q4 2022 in Review

10 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q4 2022, worth a combined $464K — up 24% from $375K a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of HURA and 1 opened new positions — a net loss of 14 holders — while 2 trimmed existing stakes and 5 added.

The largest buyer was State Street, adding an estimated $53.3K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $30K sold.

  • 10 institutional investors held TuHURA Biosciences (HURA) as of Q4 2022, down from 24 in Q3 2022.
  • Funds reported $464K of TuHURA Biosciences stock for Q4 2022, up 24% quarter-over-quarter.
  • 1 fund opened new TuHURA Biosciences positions in Q4 2022 and 15 closed out, a net change of -14 holders.
  • The largest TuHURA Biosciences buyer in Q4 2022 was State Street, an estimated $53.3K added.
  • The largest TuHURA Biosciences seller in Q4 2022 was Renaissance Technologies, an estimated $30K sold.

Based on aggregated 13F filings for Q4 2022.